Pure Biologics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of PUR?
Owner TypeNumber of SharesOwnership Percentage
Private Companies270,0007.31%
Institutions306,2698.29%
Individual Insiders517,86314%
General Public2,598,55270.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 14.9%.


Top Shareholders

Top 10 shareholders own 30.06% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.31%
Ecapital Spolka Z Ograniczona Odpowiedzialnoscia
270,000zł4.9m0%no data
5.87%
Filip Jelen
216,717zł3.9m-21.5%no data
5.14%
Tadeusz Wesolowski
189,720zł3.4m0%no data
3.81%
Forum Towarzystwo Funduszy Inwestycyjnych S.A.
140,752zł2.5m-25.8%0.34%
3.27%
Allianz Asset Management GmbH
120,630zł2.2m0%no data
2.19%
Andrzej Trznadel
81,000zł1.5m0%no data
1.65%
Norges Bank Investment Management
60,957zł1.1m0%no data
0.71%
Andrzej Kierzkowski
26,221zł471.5k0%no data
0.087%
Romuald Harwas
3,205zł57.6k0%no data
0.027%
Pieter Spee
1,000zł18.0k0%no data